|Venture Round, 12/2009 ||$500k|
|Series A, 1/2010 |
|Series A, 9/2010 ||$14.2M|
|Series B, 5/2013 ||$7M|
Acton Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on acquiring, developing and commercializing products primarily for the treatment of respiratory conditions.
The Company was founded by pharmaceutical executives experienced in respiratory product development and commercialization.
Acton is actively pursing the acquisition of products in either late-stage clinical development or which are currently being marketed.